4//SEC Filing
Boudes Pol F 4
Accession 0001133416-22-000016
CIK 0001133416other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:17 PM ET
Size
5.3 KB
Accession
0001133416-22-000016
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-24+50,000→ 50,000 totalExercise: $1.98Exp: 2032-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest as follows: 25% on each of June 30, 2022; December 31, 2022; June 30, 2023; and December 31, 2023.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001454771
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:17 PM ET
- Size
- 5.3 KB